Spivak, M.; Pahmer, M.; Delrahimnia, D.; Sapir, T.; Shifteh, D.
PRMT5 Inhibition as a Potential Strategy for KRAS Mutant CRC: Downstream Mediators of the PRMT5–KRAS Crosstalk. Curr. Issues Mol. Biol. 2025, 47, 665.
https://doi.org/10.3390/cimb47080665
AMA Style
Spivak M, Pahmer M, Delrahimnia D, Sapir T, Shifteh D.
PRMT5 Inhibition as a Potential Strategy for KRAS Mutant CRC: Downstream Mediators of the PRMT5–KRAS Crosstalk. Current Issues in Molecular Biology. 2025; 47(8):665.
https://doi.org/10.3390/cimb47080665
Chicago/Turabian Style
Spivak, Mark, Moshe Pahmer, Dorna Delrahimnia, Tzuriel Sapir, and David Shifteh.
2025. "PRMT5 Inhibition as a Potential Strategy for KRAS Mutant CRC: Downstream Mediators of the PRMT5–KRAS Crosstalk" Current Issues in Molecular Biology 47, no. 8: 665.
https://doi.org/10.3390/cimb47080665
APA Style
Spivak, M., Pahmer, M., Delrahimnia, D., Sapir, T., & Shifteh, D.
(2025). PRMT5 Inhibition as a Potential Strategy for KRAS Mutant CRC: Downstream Mediators of the PRMT5–KRAS Crosstalk. Current Issues in Molecular Biology, 47(8), 665.
https://doi.org/10.3390/cimb47080665